Mologen AG
XHAM:MGNK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mologen AG
XHAM:MGNK
|
DE |
|
Q BioMed Inc
OTC:QBIO
|
US |
|
S
|
Swarnsarita Jewels India Ltd
BSE:526365
|
IN |
|
S
|
Simris Group AB
STO:SIMRIS B
|
SE |
|
V
|
Valencia Capital Inc
XTSX:VAL.P
|
CA |
|
T
|
Tuniu Corp
F:0TUA
|
CN |
|
Gelum Resources Ltd
OTC:GMRCF
|
CA |
|
D
|
Dhanuka Realty Ltd
NSE:DRL
|
IN |
Income Statement
Earnings Waterfall
Mologen AG
Income Statement
Mologen AG
| Jun-2019 | Sep-2019 | ||
|---|---|---|---|
| Revenue | |||
| Revenue |
0
N/A
|
0
-37%
|
|
| Gross Profit | |||
| Cost of Revenue |
(6)
|
(5)
|
|
| Gross Profit |
(6)
N/A
|
(5)
+22%
|
|
| Operating Income | |||
| Operating Expenses |
(8)
|
(8)
|
|
| Selling, General & Administrative |
(5)
|
(5)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
|
| Other Operating Expenses |
(3)
|
(3)
|
|
| Operating Income |
(14)
N/A
|
(13)
+10%
|
|
| Pre-Tax Income | |||
| Interest Income Expense |
(1)
|
(1)
|
|
| Pre-Tax Income |
(15)
N/A
|
(14)
+9%
|
|
| Net Income | |||
| Tax Provision |
0
|
0
|
|
| Income from Continuing Operations |
(15)
|
(14)
|
|
| Net Income (Common) |
(15)
N/A
|
(14)
+9%
|
|
| EPS (Diluted) |
-1.32
N/A
|
-1.22
+8%
|
|